Precision Medicine Market By Technology and End User - Global Industry Analysis And Forecast To 2025

Published On : October 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC101518

Precision Medicine Market By Technology (Companion diagnostics, Big data analytics, Drug discovery, Bioinformatics, Gene sequencing and Other Technologies) and End User (CNS, Oncology, Immunology, Respiratory and Other Applications) - Global Industry Analysis And Forecast To 2025

Industry Outlook

The precision medicine (PM) is the medicinal model that includes the customization of the healthcare sector, with the therapeutic choices, medications, practices, or items being custom-made to the patient in individual. In the model, the diagnostic testing is regularly utilized for choosing proper and ideal treatments dependent on the setting of a patient's hereditary content or the cellular analysis or other molecular. Devices utilized in the PM may incorporate the molecular diagnostics, analytics, and imaging. The PM frequently includes the use of systems biology and panomic analysis to break down the reason for an patient's individual ailment at the molecular level and afterward to use the targeted treatments (perhaps in blend) to label that patient's individual ailment procedure. Therefore, the Precision Medicine Market is anticipated to expand and has tremendous scope during the forecast period. The global Precision Medicine Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

On the basis of Technology the market is further divided into Companion diagnostics, Big data analytics, Drug discovery, Bioinformatics, Gene sequencing and Other Technologies. The Drug discovery section is leading the market owing to the development in the field of pharmacogenomics that permits to predict the results of the medicines with the genetic data.

On the basis of End User the market is further divided into CNS, Oncology, Immunology, Respiratory and Other Applications. The Oncology section is leading the market share owing to rise in the number of case relate to cancer, rise in the development of more targeted treatments, etc.

Regional Insights

The North American region is leading the global Precision Medicine Market due to increase in the numbers of cases of cancer, also the regulatory measures that are favorable, various awareness initiatives & campaigns arranged by the public & government organizations, etc.

Precision Medicine Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Ferrer InCode
  • Intomics
  • Quest Diagnostics
  • F. Hoffmann-La Roche
  • NanoString Technologies
  • Silicon Biosystems
  • Laboratory Corporation of America Holdings
  • Biocrates Life Sciences
  • Novartis
  • Teva Pharmaceutical
  • Tepnel Pharma Services

Some of the key questions answered by the report are:          

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Precision Medicine Market, By Technology, Estimates and Forecast, 2014-2025 ($Million)

o   Companion diagnostics

o   Big data analytics

o   Drug discovery

o   Bioinformatics

o   Gene sequencing

o   Other Technologies

o   Precision Medicine Market, By Application, Estimates and Forecast, 2014-2025 ($Million)

o   CNS

o   Oncology

o   Immunology

o   Respiratory

o   Other Applications

 

o   Precision Medicine Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o   North America

§  North America Precision Medicine Market, By Country

o   U.S. Precision Medicine Market

o   Canada Precision Medicine Market

o   Mexico Precision Medicine Market

o   Europe

§  Europe Precision Medicine Market, By Country

o   Germany Precision Medicine Market

o   UK Precision Medicine Market

o   France Precision Medicine Market

o   Russia Precision Medicine Market

o   Italy Precision Medicine Market

o   Rest of Europe Precision Medicine Market

o   Asia-Pacific

§  Asia-Pacific Precision Medicine Market, By Country

o   China Precision Medicine Market

o   Japan Precision Medicine Market

o   South Korea  Precision Medicine Market

o   India Precision Medicine Market

o   Southeast Asia Precision Medicine Market

o   Rest of Asia-Pacific Precision Medicine Market

o   South America

§  South America Precision Medicine Market, By Country

o   Brazil Precision Medicine Market

o   Argentina Precision Medicine Market

o   Columbia Precision Medicine Market

o   Rest of South America Precision Medicine Market

o   Middle East and Africa

§  Middle East and Africa Precision Medicine Market, By Country

o   Saudi Arabia Precision Medicine Market

o   UAE Precision Medicine Market

o   Egypt Precision Medicine Market

o   Nigeria Precision Medicine Market

o   South Africa Precision Medicine Market

o   Rest of MEA Precision Medicine Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Precision Medicine  Market, By Technology

5.1.     Introduction

5.2.     Global Precision Medicine  Revenue and Market Share by Technology (2014-2018)

5.2.1.  Global Precision Medicine  Revenue and Revenue Share by Technology (2014-2018)

5.3.     Companion diagnostics

5.3.1.  Global Companion diagnostics Revenue and Growth Rate (2014-2018)

5.4.     Big data analytics

5.4.1.  Global Big data analytics Revenue and Growth Rate (2014-2018)

5.5.     Drug discovery

5.5.1.  Global Drug discovery Revenue and Growth Rate (2014-2018)

5.6.     Bioinformatics

5.6.1.  Global Bioinformatics Revenue and Growth Rate (2014-2018)

5.7.     Gene sequencing

5.7.1.  Global Gene sequencing Revenue and Growth Rate (2014-2018)

5.8.     Other Technologies

5.8.1.  Global Other Technologies Revenue and Growth Rate (2014-2018)

6.       Precision Medicine  Market, By Application

6.1.     Introduction

6.2.     Global Precision Medicine  Revenue and Market Share by Application (2014-2018)

6.2.1.  Global Precision Medicine  Revenue and Revenue Share by Application (2014-2018)

6.3.     CNS

6.3.1.  Global CNS Revenue and Growth Rate (2014-2018)

6.4.     Oncology

6.4.1.  Global Oncology Revenue and Growth Rate (2014-2018)

6.5.     Immunology

6.5.1.  Global Immunology Revenue and Growth Rate (2014-2018)

6.6.     Respiratory

6.6.1.  Global Respiratory Revenue and Growth Rate (2014-2018)

6.7.     Other Applications

6.7.1.  Global Other Applications Revenue and Growth Rate (2014-2018)

7.       Precision Medicine  Market, By Region

7.1.     Introduction

7.2.     Global Precision Medicine  Revenue and Market Share by Regions

7.2.1.  Global Precision Medicine  Revenue by Regions (2014-2018)

7.3.     North America Precision Medicine  by Countries

7.3.1.  North America Precision Medicine  Revenue and Growth Rate (2014-2018)

7.3.2.  North America Precision Medicine  Revenue (Million USD) by Countries (2014-2018)

7.3.3.  United States

7.3.3.1.  United States Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.4.  Canada

7.3.4.1.  Canada Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.5.  Mexico

7.3.5.1.  Mexico Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.     Europe Precision Medicine  by Countries

7.4.1.  Europe Precision Medicine  Revenue and Growth Rate (2014-2018)

7.4.2.  Europe Precision Medicine  Revenue (Million USD) by Countries (2014-2018)

7.4.3.  Germany

7.4.3.1.  Germany Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.4.  France

7.4.4.1.  France Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.5.  UK

7.4.5.1.  UK Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  Russia

7.4.6.1.  Russia Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  Italy

7.4.7.1.  Italy Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.     Asia-Pacific Precision Medicine  by Countries

7.5.1.  Asia-Pacific Precision Medicine  Revenue and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Precision Medicine  Revenue (Million USD) by Countries (2014-2018)

7.5.3.  China

7.5.3.1.  China Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.4.  Japan

7.5.4.1.  Japan Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5.  Korea

7.5.5.1.  Korea Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  India

7.5.6.1.  India Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.     South America Precision Medicine  by Countries

7.6.1.  South America Precision Medicine  Revenue and Growth Rate (2014-2018)

7.6.2.  South America Precision Medicine  Revenue (Million USD) by Countries (2014-2018)

7.6.3.  Brazil

7.6.3.1.  Brazil Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.4.  Argentina

7.6.4.1.  Argentina Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.5.  Columbia

7.6.5.1.  Columbia Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.     Middle East and Africa Precision Medicine  by Countries

7.7.1.  Middle East and Africa Precision Medicine  Revenue and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Precision Medicine  Revenue (Million USD) by Countries (2014-2018)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.5.  Egypt

7.7.5.1.  Egypt Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  South Africa

7.7.7.1.  South Africa Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Turkey

7.7.8.1.  Turkey Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Precision Medicine  Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.     Ferrer InCode

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Intomics

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     Quest Diagnostics

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     F. Hoffmann-La Roche

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     NanoString Technologies

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Silicon Biosystems

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Laboratory Corporation of America Holdings

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     Biocrates Life Sciences

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     Novartis

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. Teva Pharmaceutical

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

8.11. Tepnel Pharma Services

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.       Revenue and Market Share

9.       Global Precision Medicine  Market Competition, by Manufacturer

9.1.     Global Precision Medicine  Revenue and Market Share by Manufacturer (2016-2017)

9.2.     Global Precision Medicine  Price By Region (2016-2017)

9.3.     Top 5 Precision Medicine  Manufacturer Market Share

9.4.     Market Competition Trend

10.    Precision Medicine  Market Forecast (2018-2025)

10.1. Global Precision Medicine  Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Precision Medicine  Market Forecast by Regions (2018-2025)

10.2.1.      North America Precision Medicine  Market Forecast (2018-2025)

10.2.1.1. United States Precision Medicine  Market Forecast (2018-2025)

10.2.1.2. Canada Precision Medicine  Market Forecast (2018-2025)

10.2.1.3. Mexico Precision Medicine  Market Forecast (2018-2025)

10.2.2.      Europe Precision Medicine  Market Forecast (2018-2025)

10.2.2.1. Germany Precision Medicine  Market Forecast (2018-2025)

10.2.2.2. France Precision Medicine  Market Forecast (2018-2025)

10.2.2.3. UK Precision Medicine  Market Forecast (2018-2025)

10.2.2.4. Russia Precision Medicine  Market Forecast (2018-2025)

10.2.2.5. Italy Precision Medicine  Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Precision Medicine  Market Forecast (2018-2025)

10.2.3.      Asia-Pacific Precision Medicine  Market Forecast (2018-2025)

10.2.3.1. China Precision Medicine  Market Forecast (2018-2025)

10.2.3.2. Japan Precision Medicine  Market Forecast (2018-2025)

10.2.3.3. Korea Precision Medicine  Market Forecast (2018-2025)

10.2.3.4. India Precision Medicine  Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Precision Medicine  Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Precision Medicine  Market Forecast (2018-2025)

10.2.4.      South America Precision Medicine  Market Forecast (2018-2025)

10.2.4.1. Brazil Precision Medicine  Market Forecast (2018-2025)

10.2.4.2. Argentina Precision Medicine  Market Forecast (2018-2025)

10.2.4.3. Columbia Precision Medicine  Market Forecast (2018-2025)

10.2.4.4. Rest of South America Precision Medicine  Market Forecast (2018-2025)

10.2.5.      Middle East and Africa Precision Medicine  Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Precision Medicine  Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Precision Medicine  Market Forecast (2018-2025)

10.2.5.3. Egypt Precision Medicine  Market Forecast (2018-2025)

10.2.5.4. Nigeria Precision Medicine  Market Forecast (2018-2025)

10.2.5.5. South Africa Precision Medicine  Market Forecast (2018-2025)

10.2.5.6. Turkey Precision Medicine  Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Precision Medicine  Market Forecast (2018-2025)

10.3. Precision Medicine  Market Forecast by Technology (2018-2025)

10.3.1.      Precision Medicine  Forecast by Technology (2018-2025)

10.3.2.      Precision Medicine  Market Share Forecast by Technology (2018-2025)

10.4. Precision Medicine  Market Forecast by Application (2018-2025)

10.4.1.      Precision Medicine  Forecast by Application (2018-2025)

10.4.2.      Precision Medicine  Market Share Forecast by Application (2018-2025)


List of Tables

List of Tables and Figures:

Figure United States Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Canada Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Mexico Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Germany Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure France Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure UK Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Russia Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Italy Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Europe Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Korea Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Asia-Pacific Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Brazil Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Argentina Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Columbia Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of South America Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Saudi Arabia Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure United Arab Emirates Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Egypt Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Nigeria Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure South Africa Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Turkey Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Rest of Middle East and Africa Precision Medicine Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Precision Medicine Revenue and Revenue Share by Technology (2014-2018)
Figure Global Companion diagnostics Revenue and Growth Rate (2014-2018)
Figure Global Big data analytics Revenue and Growth Rate (2014-2018)
Figure Global Drug discovery Revenue and Growth Rate (2014-2018)
Figure Global Bioinformatics Revenue and Growth Rate (2014-2018)
Figure Global Gene sequencing Revenue and Growth Rate (2014-2018)
Figure Global Other Technologies Revenue and Growth Rate (2014-2018)
Table Global Precision Medicine Revenue and Revenue Share by Application (2014-2018)
Figure Global CNS Revenue and Growth Rate (2014-2018)
Figure Global Oncology Revenue and Growth Rate (2014-2018)
Figure Global Immunology Revenue and Growth Rate (2014-2018)
Figure Global Respiratory Revenue and Growth Rate (2014-2018)
Figure Global Other Applications Revenue and Growth Rate (2014-2018)
Table Global Precision Medicine Revenue by Regions (2014-2018)
Figure North America Precision Medicine Growth Rate (2014-2018)
Figure North America Precision Medicine Revenue and Growth Rate (2014-2018)
Figure North America Precision Medicine by Countries (2014-2018)
Figure North America Precision Medicine Revenue (Million USD) by Countries (2014-2018)
Figure United States Precision Medicine Growth Rate (2014-2018)
Figure United States Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Canada Precision Medicine Growth Rate (2014-2018)
Figure Canada Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Mexico Precision Medicine Growth Rate (2014-2018)
Figure Mexico Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Europe Precision Medicine Growth Rate (2014-2018)
Figure Europe Precision Medicine Revenue and Growth Rate (2014-2018)
Figure Europe Precision Medicine by Countries (2014-2018)
Figure Europe Precision Medicine Revenue (Million USD) by Countries (2014-2018)
Figure Germany Precision Medicine Growth Rate (2014-2018)
Figure Germany Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure France Precision Medicine Growth Rate (2014-2018)
Figure France Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure UK Precision Medicine Growth Rate (2014-2018)
Figure UK Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Russia Precision Medicine Growth Rate (2014-2018)
Figure Russia Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Italy Precision Medicine Growth Rate (2014-2018)
Figure Italy Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Europe Precision Medicine Growth Rate (2014-2018)
Figure Rest of Europe Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Asia-Pacific Precision Medicine Growth Rate (2014-2018)
Figure Asia-Pacific Precision Medicine Revenue and Growth Rate (2014-2018)
Figure Asia-Pacific Precision Medicine by Countries (2014-2018)
Figure Asia-Pacific Precision Medicine Revenue (Million USD) by Countries (2014-2018)
Figure China Precision Medicine Growth Rate (2014-2018)
Figure China Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Japan Precision Medicine Growth Rate (2014-2018)
Figure Japan Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Korea Precision Medicine Growth Rate (2014-2018)
Figure Korea Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure India Precision Medicine Growth Rate (2014-2018)
Figure India Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Southeast Asia Precision Medicine Growth Rate (2014-2018)
Figure Southeast Asia Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Precision Medicine Growth Rate (2014-2018)
Figure Rest of Asia-Pacific Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South America Precision Medicine Growth Rate (2014-2018)
Figure South America Precision Medicine Revenue and Growth Rate (2014-2018)
Figure South America Precision Medicine by Countries (2014-2018)
Figure South America Precision Medicine Revenue (Million USD) by Countries (2014-2018)
Figure Brazil Precision Medicine Growth Rate (2014-2018)
Figure Brazil Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Argentina Precision Medicine Growth Rate (2014-2018)
Figure Argentina Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Columbia Precision Medicine Growth Rate (2014-2018)
Figure Columbia Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of South America Precision Medicine Growth Rate (2014-2018)
Figure Rest of South America Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Middle East and Africa Precision Medicine Growth Rate (2014-2018)
Figure Middle East and Africa Precision Medicine Revenue and Growth Rate (2014-2018)
Figure Middle East and Africa Precision Medicine by Countries (2014-2018)
Figure Middle East and Africa Precision Medicine Revenue (Million USD) by Countries (2014-2018)
Figure Saudi Arabia Precision Medicine Growth Rate (2014-2018)
Figure Saudi Arabia Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure United Arab Emirates Precision Medicine Growth Rate (2014-2018)
Figure United Arab Emirates Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Egypt Precision Medicine Growth Rate (2014-2018)
Figure Egypt Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Nigeria Precision Medicine Growth Rate (2014-2018)
Figure Nigeria Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure South Africa Precision Medicine Growth Rate (2014-2018)
Figure South Africa Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Turkey Precision Medicine Growth Rate (2014-2018)
Figure Turkey Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Precision Medicine Growth Rate (2014-2018)
Figure Rest of Middle East and Africa Precision Medicine Revenue (Millions USD) and Growth Rate (2014-2018)
Table Ferrer InCode Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Intomics Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Quest Diagnostics Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Table NanoString Technologies Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Silicon Biosystems Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Laboratory Corporation of America Holdings Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biocrates Life Sciences Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Tepnel Pharma Services Precision Medicine Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Precision Medicine Market Share by Manufacturer
Figure Global Precision Medicine Revenue and Market Share by Manufacturer
Table Global Precision Medicine Price by Region (2016-2017)
Figure Top 5 Precision Medicine Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Precision Medicine Revenue (Millions USD) and Growth Rate (2018-2025)
Table Precision Medicine Market Forecast by Regions (2018-2025)
Figure North America Precision Medicine Market Forecast (2018-2025)
Figure United States Precision Medicine Market Forecast (2018-2025)
Figure Canada Precision Medicine Market Forecast (2018-2025)
Figure Mexico Precision Medicine Market Forecast (2018-2025)
Figure Europe Precision Medicine Market Forecast (2018-2025)
Figure Germany Precision Medicine Market Forecast (2018-2025)
Figure France Precision Medicine Market Forecast (2018-2025)
Figure UK Precision Medicine Market Forecast (2018-2025)
Figure Russia Precision Medicine Market Forecast (2018-2025)
Figure Italy Precision Medicine Market Forecast (2018-2025)
Figure Rest of Europe Precision Medicine Market Forecast (2018-2025)
Figure Asia-Pacific Precision Medicine Market Forecast (2018-2025)
Figure China Precision Medicine Market Forecast (2018-2025)
Figure Japan Precision Medicine Market Forecast (2018-2025)
Figure Korea Precision Medicine Market Forecast (2018-2025)
Figure India Precision Medicine Market Forecast (2018-2025)
Figure Southeast Asia Precision Medicine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Precision Medicine Market Forecast (2018-2025)
Figure South America Precision Medicine Market Forecast (2018-2025)
Figure Brazil Precision Medicine Market Forecast (2018-2025)
Figure Argentina Precision Medicine Market Forecast (2018-2025)
Figure Columbia Precision Medicine Market Forecast (2018-2025)
Figure Rest of South America Precision Medicine Market Forecast (2018-2025)
Figure Middle East and Africa Precision Medicine Market Forecast (2018-2025)
Figure Saudi Arabia Precision Medicine Market Forecast (2018-2025)
Figure United Arab Emirates Precision Medicine Market Forecast (2018-2025)
Figure Egypt Precision Medicine Market Forecast (2018-2025)
Figure Nigeria Precision Medicine Market Forecast (2018-2025)
Figure South Africa Precision Medicine Market Forecast (2018-2025)
Figure Turkey Precision Medicine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Precision Medicine Market Forecast (2018-2025)
Figure Global Precision Medicine Forecast by Technology (2018-2025)
Figure Global Precision Medicine Market Share Forecast by Technology (2018-2025)
Figure Global Precision Medicine Forecast by Technology (2018-2025)
Figure Global Precision Medicine Forecast by Application (2018-2025)
Figure Global Precision Medicine Market Share Forecast by Application (2018-2025)
Figure Global Precision Medicine Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*